hexagon
发表于 2025-3-21 19:54:05
书目名称Disease-modifying Therapy in Vasculitides影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0281270<br><br> <br><br>书目名称Disease-modifying Therapy in Vasculitides影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0281270<br><br> <br><br>书目名称Disease-modifying Therapy in Vasculitides网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0281270<br><br> <br><br>书目名称Disease-modifying Therapy in Vasculitides网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0281270<br><br> <br><br>书目名称Disease-modifying Therapy in Vasculitides被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0281270<br><br> <br><br>书目名称Disease-modifying Therapy in Vasculitides被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0281270<br><br> <br><br>书目名称Disease-modifying Therapy in Vasculitides年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0281270<br><br> <br><br>书目名称Disease-modifying Therapy in Vasculitides年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0281270<br><br> <br><br>书目名称Disease-modifying Therapy in Vasculitides读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0281270<br><br> <br><br>书目名称Disease-modifying Therapy in Vasculitides读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0281270<br><br> <br><br>
可转变
发表于 2025-3-22 00:10:19
1422-7746 dicine, connective tissue disease and clinical immunology, they present new concepts in classificiation, diagnosis and pathophysiology of the vasculitides. Evidence from experimental and clinical trials is reviewed, as well as the outlook for further research.978-3-0348-9485-2978-3-0348-8235-4Series ISSN 1422-7746 Series E-ISSN 2296-4525
uveitis
发表于 2025-3-22 02:50:54
Philip Michalk,Bertram Meimbresse rheumatoid arthritis (RA) and Crohn’s disease has revolutionized the treatment of these diseases [.-.]. The extrapolation and rigorous testing of cytokine modulation strategies in the vasculitides have enormous potential to improve therapies for this group of disorders.
SEED
发表于 2025-3-22 05:08:40
http://reply.papertrans.cn/29/2813/281270/281270_4.png
色情
发表于 2025-3-22 10:26:11
http://reply.papertrans.cn/29/2813/281270/281270_5.png
NOCT
发表于 2025-3-22 16:28:13
Intravenous immunoglobulin as immuno-modifying treatment,s of autoimmunity. There has been widespread clinical use of IgIV as a second line treatment for many autoimmune diseases with relatively few randomised studies demonstrating its clinical effectiveness.
NOCT
发表于 2025-3-22 17:33:01
http://reply.papertrans.cn/29/2813/281270/281270_7.png
conflate
发表于 2025-3-22 23:06:29
http://reply.papertrans.cn/29/2813/281270/281270_8.png
天空
发表于 2025-3-23 05:23:46
http://reply.papertrans.cn/29/2813/281270/281270_9.png
似少年
发表于 2025-3-23 09:37:16
,Interferon-α for the treatment of virus-related systemic vasculitides,itides with IFNα. Two types of IFNα are commonly prescribed, IFNα 2a and IFNα 2b. They differ by one amino acid but no difference in efficacy has been shown. The other types of IFN, that is, IFNβ and IFNγ, are not prescribed for virus-associated vasculitides.